X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (83) 83
humans (78) 78
neurosciences (64) 64
progressive supranuclear palsy (62) 62
clinical neurology (51) 51
animals (48) 48
male (48) 48
parkinson's disease (43) 43
parkinsons-disease (33) 33
diagnosis (28) 28
dopamine (28) 28
female (28) 28
neurology (28) 28
neurodegeneration (25) 25
aged (24) 24
brain (24) 24
neurons (23) 23
mice (22) 22
neurodegenerative diseases (22) 22
mice, inbred c57bl (19) 19
middle aged (19) 19
alzheimers-disease (18) 18
analysis (17) 17
article (17) 17
movement disorders (16) 16
multiple system atrophy (16) 16
nervous system diseases (16) 16
neurons - drug effects (16) 16
cells, cultured (15) 15
corticobasal degeneration (15) 15
disease (15) 15
neurons - metabolism (15) 15
dopaminergic-neurons (14) 14
brain - metabolism (13) 13
mice, transgenic (13) 13
paralysis (13) 13
pathology (13) 13
research (13) 13
aged, 80 and over (12) 12
degeneration (12) 12
neurons - pathology (12) 12
rats (12) 12
substantia-nigra (12) 12
biochemistry & molecular biology (11) 11
brain - pathology (11) 11
clinical trials (11) 11
medicine & public health (11) 11
multidisciplinary sciences (11) 11
parkinson disease - pathology (11) 11
alpha-synuclein (10) 10
atrophy (10) 10
atypical parkinsonism (10) 10
disease models, animal (10) 10
eye diseases (10) 10
substantia nigra - metabolism (10) 10
supranuclear palsy, progressive - genetics (10) 10
supranuclear palsy, progressive - pathology (10) 10
tau proteins - genetics (10) 10
tau proteins - metabolism (10) 10
disease progression (9) 9
mitochondrial complex-i (9) 9
natural-history (9) 9
neuroprotection (9) 9
proteins (9) 9
psychiatry (9) 9
supranuclear palsy, progressive - diagnosis (9) 9
tau protein (9) 9
apoptosis (8) 8
autopsy (8) 8
basal ganglia (8) 8
biomarkers (8) 8
criteria (8) 8
expression (8) 8
frontotemporal dementia (8) 8
gene expression (8) 8
genetic aspects (8) 8
lewy bodies (8) 8
magnetic resonance imaging (8) 8
mouse model (8) 8
parkinson disease - metabolism (8) 8
risk factors (8) 8
supranuclear palsy, progressive - drug therapy (8) 8
tauopathy (8) 8
adult neurogenesis (7) 7
annonacin (7) 7
brain - drug effects (7) 7
care and treatment (7) 7
cell biology (7) 7
cell death (7) 7
cell proliferation (7) 7
central nervous system diseases (7) 7
dementia (7) 7
development and progression (7) 7
differentiation (7) 7
dose-response relationship, drug (7) 7
genome-wide association (7) 7
immunohistochemistry (7) 7
life sciences (7) 7
medical and health sciences (7) 7
medicin och hälsovetenskap (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SCIENTIFIC REPORTS, ISSN 2045-2322, 09/2019, Volume 9, Issue 1, pp. 1 - 10
Journal Article
Movement Disorders, ISSN 0885-3185, 09/2019, Volume 34, Issue 9, pp. 1284 - 1293
Fifty‐five years have passed from the first description of PSP, but it is in the last decade that there has been a revolutionary change in understanding both... 
diagnosis | therapeutics | pathophysiology | progressive supranuclear palsy | Neuroprotection | Phenotypes | Progressive supranuclear palsy | New combinations | Clinical trials | Biomarkers | Paralysis
Journal Article
Neuroscience and Biobehavioral Reviews, ISSN 0149-7634, 09/2019, Volume 104, pp. 26 - 27
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1 - 8
Pesticide exposure is associated with increased risk of Parkinson’s disease (PD). We investigated in Egypt whether common variants in genes involved in... 
Parkinson's disease | Neurodegenerative diseases | Genes | Pesticides | Detoxification | Single-nucleotide polymorphism | Environmental factors | Coffee | Health risk assessment | Movement disorders
Journal Article
Neurology, ISSN 0028-3878, 07/2019, Volume 93, Issue 2, pp. e135 - e142
OBJECTIVETo verify the previously reported association between long-term use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk... 
Journal Article
Drugs & Aging, ISSN 1170-229X, 6/2019, Volume 36, Issue 6, pp. 511 - 530
Parkinson’s disease is a chronic neurodegenerative movement disorder affecting people mainly beyond their 50s. Geriatric patients with Parkinson’s disease... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology
Journal Article
Current Neurology and Neuroscience Reports, ISSN 1528-4042, 01/2019, Volume 19, Issue 2, pp. 1 - 8
Purpose of ReviewWe provide an overview about unbiased screens to identify modifiers of alpha-synuclein (Syn)-induced toxicity, present the models and the... 
Toxicity | Screen | Alpha-synuclein | Parkinson’s disease | CELLS | Parkinson's disease | MANAGEMENT | PROTECTION | HUNTINGTIN | NEUROSCIENCES | CLINICAL NEUROLOGY | YEAST | MULTIPLE SYSTEM ATROPHY | GENES | BIOLOGY | PARKINSONS-DISEASE | REVEALS | Fluorescence | Nervous system diseases | Analysis | Genomics | Cells
Journal Article
Movement Disorders, ISSN 0885-3185, 12/2015, Volume 30, Issue 14, pp. 1871 - 1872
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e102397
Journal Article
Fortschritte der Neurologie · Psychiatrie, ISSN 0720-4299, 09/2018, Volume 86, Issue S 01, pp. S21 - S29
Zusammenfassung Bei den atypischen Parkinson Syndromen handelt es sich um eine Gruppe neurodegenerativer Erkrankungen, die klinisch durch eine... 
Übersicht
Journal Article
Fortschritte der Neurologie Psychiatrie, ISSN 0720-4299, 07/2018
Journal Article
Aktuelle Neurologie, ISSN 0302-4350, 03/2017, Volume 44, Issue 2, pp. 82 - 88
Journal Article
Deutsches Arzteblatt International, ISSN 1866-0452, 02/2016, Volume 113, Issue 5, pp. 61 - 69
Journal Article
Fortschritte der Neurologie-Psychiatrie, 09/2018, Volume 86, Issue S 01, p. S21
Atypical Parkinson syndromes are a heterogeneous group of neurodegenerative diseases which present with parkinsonism and other non-motor symptoms. On the basis... 
Journal Article
Journal of Neural Transmission, ISSN 0300-9564, 1/2016, Volume 123, Issue 1, pp. 45 - 50
Psychosis in Parkinson’s disease (PD) is a frequent condition affecting >20 % of all PD patients. It is characterized by vivid dreams, nightmares, illusions,... 
Psychosis | Neurology | Neurosciences | Dopamine | Medicine & Public Health | Hallucination | Pharmacology/Toxicology | Psychiatry | Parkinson’s disease
Journal Article
Current neurology and neuroscience reports, 02/2019, Volume 19, Issue 2, p. 8
We provide an overview about unbiased screens to identify modifiers of alpha-synuclein (αSyn)-induced toxicity, present the models and the libraries that have... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.